CAS 12408-47-8

12408-47-8 9T3UU8T0QK Silodrate [USAN] Aluminum magnesium oxide silicate (Al2Mg2O2(SiO3)3), hydrate Aluminate(4-), tris(metasilicato(2-))dioxodi-, magnesium (1:2), hydrate Aluminosilicic acid (H4Al2Si3O11), magnesium salt (1:2), hydrate Silodrate Silicic acid (H2SiO3), aluminum complex Simaldrate Aluminosilicic acid (H4Al2Si3O11), magnesium salt (1:2) hydrate MP-1051 Magnesium aluminometasilicate UNII-9T3UU8T0QK

纯度 97%+现货药物标准品
CAS 号12408-47-8
分子式3*O3Si 2*Al 2*Mg H2O 2*O
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

 12408-47-8
9T3UU8T0QK
Silodrate [USAN]
Aluminum magnesium oxide silicate (Al2Mg2O2(SiO3)3), hydrate
Aluminate(4-), tris(metasilicato(2-))dioxodi-, magnesium (1:2), hydrate
Aluminosilicic acid (H4Al2Si3O11), magnesium salt (1:2), hydrate
Silodrate
Silicic acid (H2SiO3), aluminum complex
Simaldrate
Aluminosilicic acid (H4Al2Si3O11), magnesium salt (1:2) hydrate
MP-1051
Magnesium aluminometasilicate
UNII-9T3UU8T0QK CAS 12408-47-8 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品(12408-47-8 9T3UU8T0QK Silodrate [USAN] Aluminum magnesium oxide silicate (Al2Mg2O2(SiO3)3), hydrate Aluminate(4-), tris(metasilicato(2-))dioxodi-, magnesium (1:2), hydrate Aluminosilicic acid (H4Al2Si3O11), magnesium salt (1:2), hydrate Silodrate Silicic acid (H2SiO3), aluminum complex Simaldrate Aluminosilicic acid (H4Al2Si3O11), magnesium salt (1:2) hydrate MP-1051 Magnesium aluminometasilicate UNII-9T3UU8T0QK,CAS 12408-47-8),分子式 3*O3Si 2*Al 2*Mg H2O 2*O。纯度 97%+。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。

与同类药物标准品相比,的分子量为161.38 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 化学式为 3O3Si 2Al 2Mg H2O 2O 的(12408-47-8 9T3UU8T0QK Silodrate USAN Aluminum magnesium oxide silicate (Al2Mg2O2(SiO3)3), hydrate Aluminate(4-), tris(metasilicato(2-))dioxodi-, magnesium (1:2), hydrate Aluminosilicic acid (H4Al2Si3O11), magnesium salt (1:2), hydrate Silodrate Silicic acid (H2SiO3), aluminum complex Simaldrate Aluminosilicic acid (H4Al2Si3O11), magnesium salt (1:2) hydrate MP-1051 Magnesium aluminometasilicate UNII-9T3U

应用场景:(12408-47-8 9T3UU8T0QK Silodrate USAN Aluminum magnesium oxide silicate (Al2Mg2O2(SiO3)3), hydrate Aluminate(4-), tris(metasilicato(2-))dioxodi-, magnesium (1:2), hydrate Aluminosilicic acid (H4Al2Si3O11), magnesium salt (1:2), hydrate Silodrate Silicic acid (H2SiO3), aluminum complex Simaldrate A

理化性质 Physical & Chemical Properties

中文名称
分子式3*O3Si 2*Al 2*Mg H2O 2*O
分子量161.38 g/mol
外观形态白色至类白色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存,密封防潮
溶解性参考易溶于水
稳定性具有吸湿性,开封后应立即密封
化合物类型药物标准品
子类原料药标准品
CAS登记年份(估)1960年

相关专利 Related Patents

  1. 发明人王建平,钱学锋,陈志强. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 115939602 B, 授权公告日 2016-03-15.
  2. Davis P L, Williams B T, Anderson J P. "Method for the Synthesis of 12408-47-8 9T3UU8T0QK Silodrate [USAN] Aluminum magnesium oxide silicate (Al2Mg2O2(SiO3)3), hydrate Aluminate(4-), tris(metasilicato(2-))dioxodi-, magnesium (1:2), hydrate Aluminosilicic acid (H4Al2Si3O11), magnesium salt (1:2), hydrate Silodrate Silicic acid (H2SiO3), aluminum complex Simaldrate Aluminosilicic acid (H4Al2Si3O11), magnesium salt (1:2) hydrate MP-1051 Magnesium aluminometasilicate UNII-9T3UU8T0QK" [P]. US Patent, US 9540463 B2, 2018-02-24.

参考文献 Literature

  1. Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2021, 1444, 6567-6591.
  2. Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2021, 1463, 6503-6513.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...